Alvar J, Molina R, San Andre´s M, Tesouro M, Nieto J, Vitutia M, et al (1994) Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 88: 371–378.
Berman JD (1997) Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684‑703.
da Rocha ICM, Dos Santos LHM, Coura-Vital W, da Cunha GMR, Magalhães FDC, da Silva TAM (2018) Effectiveness of the Brazilian Visceral Leishmaniasis Surveillance and Control Programme in reducing the prevalence and incidence of Leishmania infantum infection. Parasites & Vectors 11, 586.
Dhiman RC, Raghavendra K, Kumar V, Kesari S, Kishore K (2003) Susceptibility status of Phlebotomusargentipes to insecticide in districts Vaishali and Patna. J Commun Dis. 35:49–51.
Foreman KJ, Lozano R, Lopez AD, Murray CJ (2012) Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 10:1.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020). Lancet 396: 1204–22.
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), (2020). Available from http://ghdx.healthdata.org/gbd-results-tool
Kishore K, Kumar V, Kesari S, Dinesh DS, Kumar AJ, Das P, et al (2006) Vector control in leishmaniasis. Indian J Med Res 123:467‑72.
Lainson R, Shaw JJ (1978) Epidemiology and ecology of leishmaniasis in Latin-America. Nature 273:595–600.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–128.
Mathur P, Samantaray JC, Vajpayee M, Samanta P (2006) Visceral leishmaniasis/human immunodeficiency virus co‑infection in India: The focus of two epidemics. J Med Microbiol 55:919‑22.
Mubayi A, Castillo‑Chavez C, Chowell G, Kribs‑Zaleta C, Ali Siddiqui N, Kumar N, et al (2010) Transmission dynamics and underreporting of Kala‑azar in the Indian state of Bihar. J TheorBiol 262:177‑85.
Muniaraj M (2014) The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Tropical parasitology 4(1):10-9.
Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al (2012) GBD 2010: design, definitions, and metrics. Lancet 380:2063–6.
Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:1005–70.
National Vector Borne Disease Control Programme, Ministry of Health & Family Welfare, GoI Operational Guidelines on Kala-Azar (Visceral Leishmaniasis) Elimination In India – 2015. Available at https://nvbdcp.gov.in/Doc/opertional-guideline-KA-2015.pdf last accessed on 5 January, 2021.
National Vector Borne Disease Control Programme (NVBDCP), Ministry of Health & Family Welfare, GoI What is the extent of problem of kala-azar in India? (2020). Available at https://nvbdcp.gov.in/index4.php?lang=1&level=0&linkid=474&lid=3749 last accessed on 12 December 2020.
Singh R, Das RK, Sharma SK (2001) Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar in India. Bull World Health Organ 79:793.
Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, et al (2011) Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus‑coinfected patients: 2‑year treatment outcomes in Bihar, India. Clin Infect Dis 53:e91‑8.
Sundar S, Chakravarty J (2012) Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India 25:85–91.
Thakur CP, Kumar M, Pandey AK (1991) Evaluation of efficacy of longer durations of therapy of fresh cases of kala‑azar with sodium stibogluconate. Indian J Med Res 93:103‑10.
Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK (1993) Amphotericin B in resistant kala‑azar in Bihar. Natl Med J India 6:57‑60.
Thakur CP (2007) A new strategy for elimination of kala‑azar from rural Bihar. Indian J Med Res 126:447‑51.
Thakur CP, Meenakshi Thakur AK, Thakur S (2009) Newer strategies for the kala‑azar elimination programme in India. Indian J Med Res 129:102‑4.
The World Bank (2020). Current health expenditure (% of GDP). Available at https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?name_desc=false last accessed on 11 December 2020.
The World Bank (2020). World Bank Country and Lending Groups. Available at https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups last accessed on 11 December 2020.
Werneck GL, Costa CHN, de Carvalho FAA, Pires e Cruz MdS, Maguire JH, et al. (2014) Effectiveness of Insecticide Spraying and Culling of Dogs on the Incidence of Leishmaniainfantum Infection in Humans: A Cluster Randomized Trial in Teresina, Brazil. PLoSNegl Trop Dis 8(10): e3172.
World Health Organization. Geneva: Leishmaniasis—Fact sheet Updated on March 2020. Available at https://www.who.int/news-room/fact-sheets/detail/leishmaniasis last accessed on 11 December 2020.